Клініко-анамнестична характеристика хворих з клінічними виявами атеросклеротичного ураження артерій нижніх кінцівок залежно від поліморфізму Т(–786)С промотора гена ендотеліальної NO-синтази

В.Й. Целуйко, Л.М. Яковлева, О.Д. Ярова

Література

1. Drozdovska SB. T-786 → with the polymorphism of the promoter of the eNOS gene (endothelial NO-synthase) in Ukrainian athletes. Problems of Ecological and Medical Genetics and Clinical Immunology. 2012;6:46-53. (in Ukr.).
2. Kochetov AG, Lyang OV, Masenko VP, et al. Methods of statistical processing of medical data. Moskva, 2012. 42 p. (in Rus.).
3. Malygina NA, Kostomarova IV, Vodolagina NN, et al. Genes of atherosclerosis and cardiovascular diseases. Clinical Medicine. 2011;89(3):14-18. (in Rus.).
4. Parkhomenko AN, Lutai YaM, Irkin OI, et al. Clinical and diagnostic significance of endothelial NO synthetase gene polymorphism in patients with acute coronary syndromes. Emergency medicine. 2014;3(58):45-54. (in Rus.).
5. Tseluyko VY, Yakovleva LM. Clinical characteristics and comparative estimation of atherosclerotic lesion of different vascular basins in patients with chronic ischemic heart disease depending on polymorphism T (-786) With promoter of endothelial NO synthase. Serce i sudyny [Heart and vessels]. 2013;4:95-102. (in Ukr.).
6. Telyuko VYa, Yakovleva LM, Bondar TM. The role of T-786C polymorphism of endothelial NO synthase gene in disturbances of nitrous oxide metabolism and atherosclerosis development. Ukr Cardiol J. 2012;4:69-73. (in Ukr.).
7. Tseluiko VY, Yakovleva LM. Influence of endophthalmic NO-synthase T-786C polymorphism on the prognosis and efficacy of statins in patients with coronary heart disease during long-term observation. Medicine of Ukraine. 2013;9-10(175-176):90-93. (in Ukr.).
8. Bhatt DL, Eagle KA, Ohman EM. et al. REACH Registry Investigators. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis. J Amer Med Association. 2010;304(12):1350-1357.
9. Forstermann U, Sessa W. Nitric oxide synthases: regulation and function. Eur Heart J. 2012;33:829-837.
10. Kathiresan S, Srivastava D. Genetics of human cardiovascular disease. Cell. 2012;148(6):1242-1257.
11. Key Data Elements and Definitions for Peripheral Atherosclerotic Vascular Disease / A Report of the American College of Cardiology Foundation. J Amer Coll Cardiology. 2012;59(3):294-353.
12. Kovacic S, Bakran M. Genetic Susceptibility to Atherosclerosis. Stroke Research and Treatment. 2012;2012:5.
13. Leeper N, Kullo I, Cooke J. Genetics of peripheral artery disease. Circulation. 2012;125:3220-3228.
14. Lieb W, Vasan RS. Genetics of coronary artery disease. Circulation. 2013;128(10):1131-1138.
15. Tsujimura Т, Ishihara Т, Iida О, et al. Syntax score is an independent predictor of 4-years mortality in patients with peripheral artery disease. J Amer Coll Cardiology. 2015;65(10).
16. Wang TJ. Assessing the role of circulating, genetic, and imaging biomarkers in cardiovascular risk prediction. Circulation. 2011;123:551-565.